Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trialJudith Bjöhle, Thomas Hatschek, Jenny Bergqvist et al.|Breast Cancer Research and Treatment|2013Cited by 39
Current treatment landscape of HR+/HER2− advanced breast cancer in the Nordics: a modified Delphi studyJürgen Geisler, Sophie Yammeni, Barbro Holm et al.|Acta Oncologica|2023Cited by 6